Literature DB >> 34267869

Novel METTL3 Modulators for Treating Acute Myeloid Leukemia (AML).

Ram W Sabnis1.   

Abstract

Entities:  

Year:  2021        PMID： 34267869      PMCID： PMC8274067          DOI： 10.1021/acsmedchemlett.1c00280

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN： 1948-5875            Impact factor:   4.632


× No keyword cloud information.
  5 in total

Review 1.  Novel insights into the m6A-RNA methyltransferase METTL3 in cancer.

Authors:  Yiqing Cai; Rui Feng; Tiange Lu; Xiaomin Chen; Xiangxiang Zhou; Xin Wang
Journal:  Biomark Res       Date:  2021-04-20

Review 2.  m6 A RNA methylation: from mechanisms to therapeutic potential.

Authors:  P Cody He; Chuan He
Journal:  EMBO J       Date:  2021-01-20       Impact factor: 11.598

Review 3.  Roles of METTL3 in cancer: mechanisms and therapeutic targeting.

Authors:  Chengwu Zeng; Wanxu Huang; Yangqiu Li; Hengyou Weng
Journal:  J Hematol Oncol       Date:  2020-08-27       Impact factor: 17.388

Review 4.  The role of RNA N 6-methyladenosine methyltransferase in cancers.

Authors:  Jiali Huang; Zhenyao Chen; Xin Chen; Jun Chen; Zhixiang Cheng; Zhaoxia Wang
Journal:  Mol Ther Nucleic Acids       Date:  2021-01-01       Impact factor: 8.886

Review 5.  N6 -methyladenosine (m6A) RNA modification in human cancer.

Authors:  Fu-Chun Huo; Zhi-Man Zhu; Dong-Sheng Pei
Journal:  Cell Prolif       Date:  2020-10-07       Impact factor: 8.755
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.